74
Participants
Start Date
October 31, 2016
Primary Completion Date
August 31, 2017
Study Completion Date
August 31, 2017
TEZ
IVA
VX-440
Matched Placebo
The Arizona Board of Regents on behalf of the University of Arizona, Tucson
Stanford University, Palo Alto
University of California, San Francisco
National Jewish Health, Denver
Joe Di Maggio Cystic Fibrosis & Pulmonary Center, Hollywood
Central Florida Pulmonary Group, Orlando
St. Luke's CF Center of Idaho, Boise
Cystic Fibrosis Center of Chicago, Glenview
The Johns Hopkins Hospital, Baltimore
Boston Children's Hospital, Boston
Massachusetts General Hospital Cystic Fibrosis Center, Boston
University of Minnesota, Minneapolis
New York Medical College, Hawthorne
Long Island Jewish Medical Center, New Hyde Park
Columbia University Medical Center, New York
Nationwide Children's Hospital, Columbus
Respiratory Diseases of Children and Adolescents, Oklahoma City
UPMC OSPARS Children's Hospital of Pittsburgh, Pittsburgh
Sanford Children's Specialty Clinic Sanford Research USD, Sioux Falls
The University of Texas Southwestern Center, Dallas
Children's Hospital of the Kings Daughters, Norfolk
Seattle Children's Hospital, Seattle
Royal Adelaide Hospital, Adelaide
Prince Charles Hospital, Chermside
John Hunter Hospital & Hunter Medical Research Institute, New Lambton Heights
Medizinische Universitat Innsbruck, Innsbruck
Universitair Ziekenhuis Brussel, Brussels
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven
St. Paul's Hopsital, Vancouver
St. Michael's Hospital, Toronto
Juliane Marie Center, Righospitalet, Copenhagen
University Hospital Cologne, Cologne
Mukeviszidose-Zentrum am Universtitatsklinikum Jena, Jena
Pneumologische Praxis Pasing, München
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan
Hospital Universitari Vall d´Hebron Servicio de Broncoscopia, Barcelona
Hospital Universitario Virgen del Rocio, Seville
Heart of England NHS Foundation Trust, Birmingham
Royal Brompton & Harefield NHS Foundation Trust, Royal Brompton Hospital, London
Southampton University Hospitals NHS Foundation Trust, Southampton
Vertex Pharmaceuticals Incorporated
INDUSTRY